Effects of JL13, a pyridobenzoxazepine compound, in dopaminergic and glutamatergic models of antipsychotic activity-Reference-Cited by-同舟云学术

Effects of JL13, a pyridobenzoxazepine compound, in dopaminergic and glutamatergic models of antipsychotic activity

Published:2020-12-29 Issue:1 Volume:32 Page:2-8
ISSN:0955-8810
Container-title:Behavioural Pharmacology
language:en
Short-container-title:

Author:

Andrade Yane C.P.,Ropke Jivago,Viana Thércia G.,Fanelli Chiara,Minaldi Elisa,Batista Luara A.,Issy Ana C.,Del Bel Elaine A.,Rodrigues Lívia C.M.,Liégeois Jean-François,Moreira Fabrício A.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Psychiatry and Mental health,Pharmacology

Reference38 articles.

1. Comparative study of typical neuroleptics, clozapine and newly synthesized clozapine-analogues: correlations between neurochemistry and behaviour.;Bruhwyler;Behav Pharmacol,1992

2. JL13, a pyridobenzoxazepine compound with potential atypical antipsychotic activity: a review of its behavioural properties.;Bruhwyler;Pharmacol Res,1997

3. Schizophrenia: from dopamine to glutamate and back.;Carlsson;Curr Med Chem,2004

4. The behavioral effects of acute and chronic JL 13, a putative antipsychotic, in Cebus non-human primates.;Casey;Psychopharmacology (BERL),2001

5. Effects of the monoamine stabilizer (-)-OSU6162 on locomotor and sensorimotor responses predictive of antipsychotic activity.;da Silveira;Naunyn Schmiedebergs Arch Pharmacol,2018

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of the promoter haplotype in CDK5 gene with schizophrenia in a Korean population;Psychiatry Research;2022-10

2. 1,5‐Benzoxazepines as a unique and potent scaffold for activity drugs: A review;Archiv der Pharmazie;2021-08-08